Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

BARDA is seeking qualified contractors to provide end‑to‑end vaccine medical countermeasure (MCM) capabilities for pandemic influenza, including candidate‑virus generation, seed‑lot production, bulk antigen and adjuvant manufacturing, formulation/fill‑finish, labeling, packaging, storage, shipping, analytical testing, non‑clinical and clinical study support, and related regulatory and data‑reporting activities. The effort will be structured as a 5‑year base IDIQ with a single optional 5‑year extension, allowing multiple awardees to compete for task orders or BPA calls across a broad suite of activities. Mandatory eligibility requires an FDA‑licensed influenza vaccine or a filed Biologics License Application. The contract includes extensive reporting, security, and compliance requirements (e.g., OPSEC, data rights, human‑subject and animal‑welfare regulations).